Growth Metrics

Cresco Labs (CRLBF) Long-Term Deferred Tax (2019 - 2026)

Cresco Labs filings provide 8 years of Long-Term Deferred Tax readings, the most recent being $13.6 million for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax rose 5.58% to $13.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $13.6 million, a 5.58% increase, with the full-year FY2025 number at $13.5 million, up 2.85% from a year prior.
  • Long-Term Deferred Tax hit $13.6 million in Q1 2026 for Cresco Labs, up from $13.5 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $17.6 million in Q2 2024 to a low of $26000.0 in Q4 2022.
  • Median Long-Term Deferred Tax over the past 5 years was $12.4 million (2025), compared with a mean of $10.7 million.
  • Biggest five-year swings in Long-Term Deferred Tax: crashed 99.6% in 2022 and later surged 44311.54% in 2023.
  • Cresco Labs' Long-Term Deferred Tax stood at $26000.0 in 2022, then surged by 44311.54% to $11.5 million in 2023, then increased by 13.68% to $13.1 million in 2024, then increased by 2.85% to $13.5 million in 2025, then grew by 1.09% to $13.6 million in 2026.
  • The last three reported values for Long-Term Deferred Tax were $13.6 million (Q1 2026), $13.5 million (Q4 2025), and $12.4 million (Q3 2025) per Business Quant data.